Tonix ends 16-year hiatus in fibromyalgia treatment
Tonix Pharma is preparing to launch a new therapy for fibromyalgia that analysts predict could make hundreds of millions of dollars in annual sales.
Novo Nordisk claims first GLP-1 approval in MASH
Under pressure from rivals in the GLP-1 space, Novo Nordisk has been given a leg-up with a first-in-class approval for Wegovy in liver disease MASH.
Pfizer suffers another hit to its GBT sickle cell portfolio
Pfizer's $5.4 billion takeover of Global Blood Therapeutics three years ago is starting to look like a poor deal.
Perspectives in viral clearance
Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
7th TIL Therapies Summit
Driving the Next Generation of TIL Therapies for Solid Tumors
3rd Donor Selection & Cell Source Summit
Transforming Off-The-Shelf Therapies From the Start
LEAP TA: Life Sciences
Reimagine Hiring Tactics to Compete for the Best Life Sciences Talent
MASH Drug Development Summit
Advancing Efficacious MASH Therapeutics in the Evolving Metabolic Landscape
2nd World Companion Diagnostics & Liquid Biopsy Summit APAC
The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies